Exchange: NASDAQ·Updated 07:30 PM EDT

VRXA Veraxa Biotech AG

$1.49
$0.04
(2.74%)
Today
Closed $1.42
$0.0698
(4.92%)
After Hours
Mkt Cap$215.69M
Vol49,265.00

About VRXA

Veraxa Biotech Holding AG engages in operating an oncology-focused biotechnology company, which is the Veraxa Biotech AG (Company). The Company focuses on the development of novel antibody-based drug platforms for the treatment of cancer. The company was founded on June 25, 2025 and is headquartered in Zurich, Switzerland.
48

Neutral Sentiment

How do you feel about VRXA?

Advertisement|Remove ads.